QA: Acura Pharmaceuticals INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000786947_2021_Acura_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0000786947, Acura Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 1,179,000
1 IntangibleAssetsNetIncludingGoodwill 73,000
2 PropertyPlantAndEquipmentNet 484,000
3 remainder_Assets 0
4 LiabilitiesCurrent 7,522,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 105,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,929,144
9 ResearchAndDevelopmentExpense 2,115,095
10 remainder_Expenses 457,764
11 remainder_Revenues 3,872,078
12 remainder_NetIncome -74,591
13 remainder_ComprehensiveNetIncome 18,740
  yvar yval
0 Assets 1,736,000
1 Liabilities 7,627,000
2 Expenses 5,502,003
3 Revenues 3,872,078
4 StockholdersEquity -5,891,000
5 NetIncome -1,704,516
6 ComprehensiveNetIncome -1,695,146
7 BaseVar 9,415,206
8 EconomicCapitalRatiobeforeLimitedLiability -3.11
9 EconomicCapitalRatio 0.652

Edgar->Model Mapping

Feature Distribution

Change over Time